BrilliMedical International Corporation

Value-added investor focused on seed to early-stage medical device innovations. Evaluates opportunities that have animal testing data or proof-of-concept prototypes. Typical investment size is $0.5–$5M. Operates with an experienced management and advisory team that provides regulatory, clinical, prototyping and market-entry support across North America, Asia and Europe.